Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Concierge Medicine Market 

5.1. COVID-19 Landscape: Concierge Medicine Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Concierge Medicine Market, By Application

8.1. Concierge Medicine Market, by Application, 2023-2032

8.1.1. Primary Care

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Cardiology

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. Pediatrics

8.1.3.1. Market Revenue and Forecast (2021-2032)

8.1.4. Psychiatry

8.1.4.1. Market Revenue and Forecast (2021-2032)

8.1.5. Internal Care

8.1.5.1. Market Revenue and Forecast (2021-2032)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Concierge Medicine Market, By Ownership

9.1. Concierge Medicine Market, by Ownership, 2023-2032

9.1.1. Independent

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Group

9.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Concierge Medicine Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Application (2021-2032)

10.1.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Application (2021-2032)

10.1.3.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Application (2021-2032)

10.1.4.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Application (2021-2032)

10.2.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Application (2021-2032)

10.2.3.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Application (2021-2032)

10.2.4.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Application (2021-2032)

10.2.5.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Application (2021-2032)

10.2.6.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Application (2021-2032)

10.3.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Application (2021-2032)

10.3.3.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Application (2021-2032)

10.3.4.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Application (2021-2032)

10.3.5.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Application (2021-2032)

10.3.6.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Application (2021-2032)

10.4.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Application (2021-2032)

10.4.3.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Application (2021-2032)

10.4.4.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Application (2021-2032)

10.4.5.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Application (2021-2032)

10.4.6.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Application (2021-2032)

10.5.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Application (2021-2032)

10.5.3.2. Market Revenue and Forecast, by Ownership (2021-2032)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Application (2021-2032)

10.5.4.2. Market Revenue and Forecast, by Ownership (2021-2032)

Chapter 11. Company Profiles

11.1. PartnerMD

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Crossover Health

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. MDVIP

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. CONCIERGE CONSULTANTS & CARDIOLOGY

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Signature MD

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Peninsula Doctor

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Winstead PC

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Castle Connolly Private Health Partners,

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Specialdocs Consultants, LLC.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Specialdocs Consultants, LLC.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms